KATHLEEN SHARKEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner STUART, FL NPI 1679760086
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$6,588.48
- Category: General Payments
- Program years: PY2021–2024
- Record count: 365
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,362.62 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,362.62 | 63 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $175.21 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $144.55 | 7 |
| Merck Sharp & Dohme Corporation | $108.40 | 5 |
| GlaxoSmithKline, LLC. | $100.59 | 4 |
| Incyte Corporation | $97.44 | 4 |
| PFIZER INC. | $82.74 | 4 |
| ABBVIE INC. | $66.51 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $64.52 | 3 |
| PUMA BIOTECHNOLOGY, INC. | $61.08 | 3 |
| GENZYME CORPORATION | $57.89 | 3 |
| Celgene Corporation | $47.69 | 2 |
| Astellas Pharma US Inc | $40.29 | 2 |
| ARRAY BIOPHARMA INC | $36.97 | 2 |
| Acerta Pharma LLC | $32.97 | 2 |
| Mirati Therapeutics, Inc. | $28.64 | 1 |
| Legend Biotech USA Inc. | $26.05 | 1 |
| TerSera Therapeutics LLC | $25.51 | 1 |
| SERVIER PHARMACEUTICALS LLC | $24.96 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.33 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.22 | 1 |
| Gilead Sciences, Inc. | $22.54 | 1 |
| SOBI, INC | $19.37 | 1 |
| BeiGene USA, Inc. | $17.91 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.71 | 1 |
| TOLMAR, INC. | $16.53 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.